Skip to main content

LOOMIS SAYLES & CO L P

Position in NBIX — Neurocrine Biosciences Inc

CIK 312348 BOSTON, MA

Position in NBIX

as of Mar 31, 2026 · filed May 14, 2026
Position Value
$21,833,928
-$2,166,543 QoQ
Shares Held
165,735
-2.1% QoQ
Ownership
0.165%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
21 quarters on record
Voting authority Sole 97.946118804115.ToString("F0")% Shared 0.ToString("F0")% None 2.053881195884997.ToString("F0")%

Common Shares in NBIX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

LOOMIS SAYLES & CO L P holds $194,398,910 across 8 Drug Manufacturers - Specialty & Generic names. NBIX ranks #3 (11.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
3 NBIX
Neurocrine Biosciences Inc
This page
165,735 $21,833,928

All Filings in NBIX

Export CSV
21 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $21,833,928 165,735
2025-12-31 $24,000,471 169,220
2025-09-30 $22,575,349 160,816
2025-06-30 $17,657,433 140,484
2024-09-30 $17,321,828 150,337
2024-06-30 $22,064,370 160,270
2024-03-31 $35,160,359 254,933
2023-12-31 $33,713,298 255,869
2023-09-30 $28,904,174 256,926
2023-06-30 $19,533,207 207,139
2023-03-31 $16,499,163 163,003
2022-09-30 $202,861 1,910
2022-06-30 $200,028 2,052
2022-03-31 $190,593 2,033
2021-09-30 $25,929,747 270,355
2021-06-30 $25,578,031 262,824
2021-03-31 $24,555,333 252,497
2020-12-31 $24,165,701 252,120
2020-09-30 $19,558,846 203,399
2020-06-30 $22,631,854 185,507
2020-03-31 $14,812,599 171,145